Main outcome measures We assessed information related to the proposed methods, the specific rare disease being studied, and outcomes from the application of the methods.We summarize methods with respect to their advantages in studying health outcomes in rare diseases and provide examples of their application.Integration with Cognos Analytics allows authors to leverage their Cognos BI knowledge with TM1 cube data sources.In this webinar recording, we look at new features in Planning Analytics 2.0 and demo key concepts.feature engineering is another topic which doesn’t seem to merit any review papers or books, or even chapters in books, but it is absolutely vital to ML success.[…] Much of the success of machine learning is actually success in engineering features that a learner can understand.Results We identified 46 articles that proposed or described methods for studying patient health outcomes in rare diseases.Articles covered a wide range of rare diseases and most (72%) were published in 2008 or later.
In creating this guide I went wide and deep and synthesized all of the material I could.
We identified 16 research strategies for studying rare disease.
Innovative clinical trial methods minimize sample size requirements (n=4) and maximize the proportion of patients who receive active treatment (n=2), strategies crucial to studying small populations of patients with limited treatment choices.
What we call the Internet, was not our first attempt at making a global data network that spanned the globe. It's increasingly likely that there will be attempts to *change* the principles of the net, and the reality is that widespread hacking is the exact sort of force that brought us this working-ish system in the first place.
In this talk, I'll lay out what I see as how the Internet actually works.